期刊文献+

奥美拉唑的临床应用与不良反应

The Clinical Application and Adverse Reaction of Omeprazole
下载PDF
导出
摘要 奥美拉唑是一种新型胃酸分泌抑制剂,为治疗消化性溃疡的首选药,疗效显著,和其他药物相比是较安全和有广泛应用前途的药物。但有不良反应。因此临床治疗中要尽量避免和减少不良反应的发生。 Omeprazole is a new type of gastric acid secretion inhibitor, and is the principal drug for peptic ulcer. Contrasting with other drugs, it is safer and has widely applied future, but has some adverse reactions.So the adverse reactions should be avoided or reduced as possible in clinical application.
作者 江美芳
机构地区 宝安区人民医院
出处 《黑龙江医药》 CAS 2008年第2期82-84,共3页 Heilongjiang Medicine journal
关键词 奥美拉唑 临床应用 不良反应 Omeprazole Clinical application Adverse reaction
  • 相关文献

参考文献8

  • 1苏三江.洛赛克治疗消化性溃疡病30例临床观察[J].医学理论与实践,2004,17(2):167-167. 被引量:1
  • 2张晓东,方敬爱,武明虎.奥美拉唑导致间质性肾炎的临床分析[J].中国中西医结合肾病杂志,2006,7(9):543-543. 被引量:19
  • 3李珍.奥美拉唑致过敏性紫癜1例.新消化病学杂志,1997,5(8):525-525.
  • 4骆泽宇.奥美拉唑的临床合理应用及不良反应[J].现代中西医结合杂志,2005,14(24):3314-3315. 被引量:12
  • 5G.. J. Dove, A. J. Freeman, M, Law, et al. Natural history models for hepatitis C- related liver desease: different disease progression parameters for different settings[J].Antivir Ther, 2003(5)
  • 6M. W. Fried, M. I. Schiffman, R. Reddy. Peginterferon alfa - 2a plus ribavirin for chronic hepatitis C virus infection[J]. N Eng J Mad,2002 (3).
  • 7R. Nocente,M. Ceccanti, G. Bertazzoni. HCV infection and extrahepatic manifestations[J]. Hepatogastroenterology, 2003(5).
  • 8M. P. Manns, J. G. McHutchison, Gordon S, et al. Peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C. A randomizedtrial[J], Lancet, 2002(8).

二级参考文献13

  • 1XueS. Bed time H2blockers improve nocturnal gastric acid control in GERD patients on Proton pump inhibitors[J]. AlimentPharmacolTher,2001,15:1351.
  • 2Modin IM. Efficacy and safety of intraoenously administered pantoprazole in the treatment of gastronoma [J]. Recenti Prog Med,2001,92:456.
  • 3Caro JJ,Salas M,Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton- pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials[J]. Clin Ther,2001,23(7) :998 - 1017.
  • 4Erstad BI. Proton - pump inhibitors for acute peptic ulcer bleeding [J]. AnnPharmacolTher,2001,35: 730.
  • 5Vera Rivera M,Pou Potau M,Botey Puig A.Omerprazole-induced interstitial nephritis:a reversible cause of acute renal failure.Med Clin(Barc),2002,118 (1):39.
  • 6Michel DM,Kelly CJ.Acute interstitial nephritis.J Am Soc Nephrol,1998,9(3):506-515.
  • 7D'Adamo G,Spinelli C,Forte F,et al.Omeprazole-induced acute interstitial nephritis.Renal Fail,1997,19(1):171-175.
  • 8Montseny JJ,Meyrier A.Immunoallergic granulomatous interstitial nephritis following treatment with omeprazole.Am J Nephrol,1998,18(3):243-246.
  • 9李瑜元.幽门螺杆菌感染根除后复发的问题[J].国外医学(内科学分册),1999,26(12):521-523. 被引量:9
  • 10李俊生,嵇振岭,严航.增殖细胞核抗原在判断肝再生中的作用及奥美拉唑的促肝再生作用[J].中华普通外科杂志,2000,15(6):352-354. 被引量:5

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部